title: Obstetric management and group B streptococcal sepsis. Have we made progress? Has it made a difference?
authors.affiliation: Department of Pediatrics, University of Chicago, Illinois, USA.
authors.forename: W
authors.initials: W
authors.lastname: Meadow
authors.forename: D
authors.initials: D
authors.lastname: Ranganathan
authors.forename: P
authors.initials: P
authors.lastname: Farber
authors.forename: R
authors.initials: R
authors.lastname: Krishnankutty
authors.forename: S
authors.initials: S
authors.lastname: Bangaloor
authors.forename: M
authors.initials: M
authors.lastname: Ismail
authors.forename: J
authors.initials: J
authors.lastname: Hibbard
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002641:Chicago / Q000453:epidemiology; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D007743:Labor, Obstetric; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000382:microbiology; D012307:Risk Factors; D018805:Sepsis / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology; D013290:Streptococcal Infections / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology; D013292:Streptococcus agalactiae
chemical_list: D000900:Anti-Bacterial Agents